Download pdf
Application of induced pluripotent stem cells in Alzheimer's disease and Huntington's disease
- 1 Universiti Tunku Abdul Rahman, Kuala Lumpur, Malaysia, 43000
* Author to whom correspondence should be addressed.
Abstract
Neurodegenerative diseases are characterized by the progressive loss of neurons or their myelin sheaths, leading to dysfunction and worsening over time. In Alzheimer's disease (AD) and Huntington's disease (HD), certain specific types of neurons are symmetrically lost in the patient's brain, and these specific neuron losses cause motor, sensory, or conscious disorders of the patient. Induced pluripotent stem cells (iPSCs) are multipotent stem cells obtained through reprogramming of somatic cells. The iPSC of patient origin carries disease-related genetic and epigenetic information, and its differentiation process can reflect the development of the disease to a certain extent. This makes iPSCs an ideal tool for building a variety of disease models, including AD and HD, offering valuable insights into disease mechanisms and potential therapeutic strategies. Since most AD and HD still lack effective treatment methods, clarifying the possible pathogenesis of AD and HD will become a prerequisite and foundation for effective prevention and development of the disease and finding effective treatment methods, which is of great theoretical and practical significance for improving the quality of life and longevity of the elderly.
Keywords
Neurodegenerative diseases, Alzheimer's disease, Huntington's disease, Induced pluripotent stem cells
[1]. Wu, H., & Jin, C. (2018). Research progress on the pathogenesis of neurodegenerative diseases. Journal of Toxicology, 06, 484-488. doi:10.16421/j.cnki.1002-3127.2018.06.013.
[2]. Xue, X., Guo, X., Li, M., & Luo, H. (2015). Advances in the pathogenesis of neurodegenerative diseases. Chinese Journal of Gerontology, 11, 3149-3152. doi:CNKI:SUN:ZLXZ.0.2015-11-135.
[3]. Wang D. (2007). Research on the mechanism of neurodegenerative diseases (doctoral dissertation, Huazhong University of Science and Technology). https://kns.cnki.net/KCMS/detail/detail.aspx?dbname=CDFD0911&filename=2009033914.nh
[4]. Tang, J., Fu J., Chai, J., & Tang, X.(2016). Advances in the application of induced pluripotent stem cells in the construction and treatment of Alzheimer's disease model. Shandong Medicine, 27, 101-103. doi:CNKI:SUN:SDYY.0.2016-27-036.
[5]. Liu, T. (2016). Research on the pathogenesis of Huntington dance disease based on iPS cell line (Master's thesis, North China University of Technology). Retrieved from https://kns.cnki.net/KCMS/detail/detail.aspx? dbname=CMFD201701&filename=1016784339.nh
[6]. Zhao, M. (2022). Research on the process of gastrodia enzyme and its anti-Alzheimer's disease (Master's thesis, Guizhou University). Retrieved from https://kns.cnki.net/KCMS/detail/detail.aspx?dbname=CMFDTEMP&filename=1022712921.nh
[7]. Lu, X., Luo, X., Song, Y., Liu, Y., Sun, X. & Li, C. (2024). Research progress on the pathogenesis of Alzheimer's disease. International Journal of Geriatrics, 05, 619-623. doi:CNKI:SUN:GWLL.0.2024-05-021.
[8]. Zhang, L. (2021). Study on the influence of energy metabolism in the induction and differentiation of neural stem cells and neurons in patients with Alzheimer's disease (Master’s thesis, Shenyang Pharmaceutical University).
[9]. Liu, X., Wu, D., & Wu, Y. (2013). The current situation and future of stem cell treatment of Alzheimer's disease. China Tissue Engineering Research, 40, 7132-7137. doi:CNKI:SUN:XDKF.0.2013-40-019.
[10]. Zhu, S., & Li, F. (2017). Advances in the application of induced pluripotent stem cells in the treatment of Alzheimer's disease. Research on tissue engineering in China, 21(21), 3426-3431.
[11]. Liu, C., Lu, X., Zheng, X., & Qing, H. (2008). Research progress on the pathogenesis of Huntington's disease. Biotechnology Newsletter, 04, 619-622. doi:CNKI:SUN:SWTX.0.2008-04-041.
[12]. Zhang, B., Song, F., Yin, X., Xia, K., Tian, J., Huang, J. & Xia, J. (2006). A study of the IT15 gene of two Huntington's disease families. Genetics, 11, 1345-1349. doi:10.16288/j.yczz.2006.11.002.
Cite this article
Chi,J. (2025). Application of induced pluripotent stem cells in Alzheimer's disease and Huntington's disease. Theoretical and Natural Science,96,15-19.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 5th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).